We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sankyo Sues Nissin Over Mevalotin Patent

Law360 (April 20, 2004, 12:00 AM EDT) -- Japanese drug maker Sankyo has filed a lawsuit against domestic rival Nissin Pharmaceutical over its flagship hyperlipidaemia drug Mevalotin (pravastatin), which Sankyo developed after discovering the world’s first cholesterol inhibitor....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.